Average Co-Inventor Count = 5.98
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (3 from 2,943 patents)
2. Novira Therapeutics, Inc. (3 from 44 patents)
3. Merck Canada Inc. (3 from 40 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Pipeline Therapeutics, Inc. (1 from 4 patents)
10 patents:
1. 11512090 - Muscarinic acetylcholine Mreceptor antagonists
2. 10710959 - Sulfide alkyl compounds for HBV treatment
3. 10392375 - Heteroaryl compounds as IRAK inhibitors and uses thereof
4. 10196351 - Sulfide alkyl compounds for HBV treatment
5. 10059701 - Heteroaryl compounds as IRAK inhibitors and uses thereof
6. 9969710 - Heteroaryl compounds as IRAK inhibitors and uses thereof
7. 9597332 - Sulfide alkyl compounds for HBV treatment
8. 8987195 - HCV NS3 protease inhibitors
9. 8343968 - Case of renin inhibitors
10. 8063105 - Renin inhibitors